GF Fund Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$484K Sell
2,716
-60
-2% -$9.8K 0.01% 218
2026
Q2
$416K Sell
2,776
-130
-4% -$14.1K 0.01% 223
2026
Q1
$268K Buy
2,906
+365
+14% +$36.6K ﹤0.01% 262
2025
Q4
$260K Sell
2,541
-142
-5% -$12.7K ﹤0.01% 268
2025
Q3
$168K Sell
2,683
-481
-15% -$26.2K ﹤0.01% 305
2025
Q2
$165K Hold
3,164
– – ﹤0.01% 334
2025
Q1
$135K Buy
3,164
+570
+22% +$24.6K ﹤0.01% 346
2024
Q4
$79.2K Buy
+2,594
New +$73K ﹤0.01% 349

Other funds holding GH

GF Fund Management's GH Position: Q3 2026 in Review

GF Fund Management reduced its Guardant Health (GH) stake by 2.2% in Q3 2026, selling an estimated $9.8K and leaving 2,716 shares worth $484K. The position accounts for 0.01% of the portfolio, ranked #218.

GF Fund Management first reported a position in GH in Q4 2024 and has held it in 8 quarters since. 511 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • GF Fund Management held 2,716 shares of Guardant Health worth $484K as of Q3 2026.
  • GF Fund Management sold 60 Guardant Health shares in Q3 2026, an estimated $9.8K.
  • Guardant Health made up 0.01% of GF Fund Management's portfolio in Q3 2026, its #218 holding.
  • GF Fund Management first reported a position in Guardant Health in Q4 2024 and has held it in 8 quarters since.
  • 511 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.